Alamar Biosciences, Inc. (NASDAQ:ALMR – Get Free Report) Director Nicholas Naclerio purchased 235,294 shares of the stock in a transaction dated Monday, April 20th. The stock was purchased at an average price of $17.00 per share, with a total value of $3,999,998.00. Following the completion of the acquisition, the director directly owned 507,076 shares in the company, valued at approximately $8,620,292. The trade was a 86.57% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Alamar Biosciences Price Performance
Shares of NASDAQ ALMR remained flat at $22.00 during trading on Monday. The stock had a trading volume of 1,068,914 shares. Alamar Biosciences, Inc. has a 1-year low of $21.50 and a 1-year high of $24.50.
Featured Stories
Receive News & Ratings for Alamar Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alamar Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
